Oncogenic tyrosine kinases such as p210BCR-ABL, the causative mutation in chronic myelogenous leukemia (CML), and Src target DOK1 for ubiquitin-mediated proteasomal degradation [7], therefore promoting cell proliferation. The gene discussed is SRC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.